Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine and Bifidobacterium in Prediabetes and Diabetes
NCT03330184Completed
- Sponsor
- Xijing Hospital
- Start
- Oct 2015
- Primary completion
- Apr 2018
- Modality
- Small Molecules, Live Biotherapeutic Products
01
Overview
Randomised, double-blind trial of berberine and Golden Bifid in prediabetes and type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Xijing Hospital. Primary endpoint: Change of absolute value of fasting plasma glucose at 16 weeks. Started Oct 2015; status: completed.
02
Drugs
berberineGolden Bifid
03
Conditions
prediabetestype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03330184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03330184.